# abrdn Precious Metals Basket ETF Trust: financial statements, quarterly

GLTR · NYSE · CIK 1483386 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gltr.md) · [Financials](/companies/gltr/financials.md) · [Filings](/companies/gltr/filings.md) · [Insiders](/companies/gltr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gltr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(3.2)](/filings/0001999371-24-014549.md) | [60.4 d](/filings/0001999371-26-004970.md) | [31.6](/filings/0001999371-25-005706.md) | [80.6](/filings/0001999371-25-010851.md) | [93.0](/filings/0001999371-25-017269.md) | [(34.9) d](/filings/0001999371-26-004970.md) | [192](/filings/0001999371-26-010351.md) | [88.1](/filings/0001999371-26-017416.md) | [282](/filings/0001999371-25-017269.md) | [504 d](/filings/0001999371-26-004970.md) | [62.8](/filings/0001999371-26-010351.md) | [(443)](/filings/0001999371-26-017416.md) |
| Basic EPS | $ per share | [(0.29)](/filings/0001999371-24-014549.md) | not reported | [3.11](/filings/0001999371-25-005706.md) | [8.24](/filings/0001999371-25-010851.md) | [9.76](/filings/0001999371-25-017269.md) | not reported | [19.64](/filings/0001999371-26-010351.md) | [8.55](/filings/0001999371-26-017416.md) | [26.40](/filings/0001999371-25-017269.md) | not reported | [4.73](/filings/0001999371-26-010351.md) | [(32.60)](/filings/0001999371-26-017416.md) |

- Gross profit: not reported
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [937](/filings/0001839882-23-030166.md) | [959](/filings/0001839882-25-012444.md) | [942](/filings/0001999371-24-005865.md) | [992](/filings/0001999371-24-009837.md) | [1,072](/filings/0001999371-24-014549.md) | [1,040](/filings/0001999371-26-004970.md) | [1,327](/filings/0001999371-25-005706.md) | [1,436](/filings/0001999371-25-010851.md) | [1,848](/filings/0001999371-25-017269.md) | [2,579](/filings/0001999371-26-017416.md) | [2,908](/filings/0001999371-26-010351.md) | [2,460](/filings/0001999371-26-017416.md) |
| Total liabilities | $m | [0.5](/filings/0001839882-23-030166.md) | [0.5](/filings/0001839882-25-012444.md) | [0.5](/filings/0001999371-24-005865.md) | [0.5](/filings/0001999371-24-009837.md) | [0.5](/filings/0001999371-24-014549.md) | [0.5](/filings/0001999371-26-004970.md) | [0.7](/filings/0001999371-25-005706.md) | [0.7](/filings/0001999371-25-010851.md) | [0.9](/filings/0001999371-25-017269.md) | [1.3](/filings/0001999371-26-017416.md) | [1.5](/filings/0001999371-26-010351.md) | [1.2](/filings/0001999371-26-017416.md) |
| Shareholders' equity | $m | [937](/filings/0001999371-24-014549.md) | [959](/filings/0001999371-26-004970.md) | [942](/filings/0001999371-25-010851.md) | [991](/filings/0001999371-25-017269.md) | [1,072](/filings/0001999371-25-017269.md) | [1,040](/filings/0001999371-26-017416.md) | [1,326](/filings/0001999371-26-017416.md) | [1,435](/filings/0001999371-26-017416.md) | [1,847](/filings/0001999371-25-017269.md) | [2,577](/filings/0001999371-26-017416.md) | [2,906](/filings/0001999371-26-017416.md) | [2,459](/filings/0001999371-26-017416.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2011-03-31) | Q2 FY2011 (2011-06-30) | Q3 FY2011 (2011-09-30) | Q4 FY2011 (2011-12-31) | Q1 FY2012 (2012-03-31) | Q2 FY2012 (2012-06-30) | Q3 FY2012 (2012-09-30) | Q4 FY2012 (2012-12-31) | Q1 FY2013 (2013-03-31) | Q2 FY2013 (2013-06-30) | Q3 FY2013 (2013-09-30) | Q4 FY2013 (2013-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.0](/filings/0000930413-12-002980.md) | [0.0](/filings/0000930413-12-004466.md) | [0.0](/filings/0001483386-12-000003.md) | [0.0 d](/filings/0001483386-14-000002.md) | [0.0](/filings/0001483386-13-000007.md) | [0.0](/filings/0001483386-13-000013.md) | [0.0](/filings/0001483386-13-000016.md) | [0.0 d](/filings/0001483386-15-000002.md) | [0.0](/filings/0001483386-14-000017.md) | [0.0](/filings/0001483386-14-000021.md) | [0.0](/filings/0001483386-14-000032.md) | [0.0 d](/filings/0001483386-16-000021.md) |
| Share repurchases | $m | [8.7](/filings/0000930413-12-002980.md) | [39.7](/filings/0000930413-12-004466.md) | [27.5](/filings/0001483386-12-000003.md) | [44.9 d](/filings/0001483386-14-000002.md) | [5.0](/filings/0001483386-13-000007.md) | [8.7](/filings/0001483386-13-000013.md) | [0.0](/filings/0001483386-13-000016.md) | [0.0 d](/filings/0001483386-15-000002.md) | [0.0](/filings/0001483386-14-000017.md) | [3.8](/filings/0001483386-14-000021.md) | [0.0](/filings/0001483386-14-000032.md) | [16.8 d](/filings/0001483386-16-000021.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 13,700,000 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001999371-26-017416.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.